You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Danaher
since
auto-detected in 12 stories
5 months ago
Danaher shares fell on the news that it was acquiring medtech player Masimo.
Danaher to buy Masimo in $9.9 billion deal in diagnostics push ⊕
The companies said on Tuesday that Danaher will pay $180 per share to buy Masimo. The offer represents a premium of 38.3% to Masimo's last close.
Stocks making the biggest moves premarket: Warner Bros. Discovery, Paramount Skydance, Masimo, Danaher & more ○
found
These are the stocks posting the largest moves in early trading.
Danaher closes in on a nearly $10bn deal for med tech company Masimo ○
Device maker is in a long-running intellectual property dispute with Apple
Danaher stock fails to rise on solid earnings — leading us to question what's next ⊕
While the quarter was solid and 2026 is shaping up to be better than 2025, the progress has been slower than we would like.
7 months ago
Why Wall Street and Jim Cramer think Danaher stock is 'ready to go for a romp' ⊕
Danaher is finally turning the corner. CNBC's Jim Cramer sees it. Wall Street does, too.
Jim Cramer has faith in Danaher's turnaround as life sciences comes back to life ⊕
Life sciences stocks are seeing a resurgence — and that's good news for Danaher.
8 months ago
Danaher stock may be turning the corner. What needs to happen to keep it that way ⊕
Danaher's rebound is generating optimism, but there's still work ahead for the company to hit is 2026 growth targets.
9 months ago
Danaher gives investors reasons to stick around, sending beaten-up shares flying ⊕
The supplier of tools to drugmakers and hospitals is set up for a stronger 2026.
12 months ago
Danaher's imperfect quarter is good enough for us to stay the course ○
Shares fluctuated between gains and losses in Tuesday's session.